Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
WorkCompWire
Article
Beyond Labels – Mental Health Language Decoded
Workers' Comp
News Release
Enlyte Drug Trends Report Indicates Significant Drop of Opioid Use in Comp
Overall opioid utilization down nearly 10%; sustained-release opioids drop by over 10% SAN DIEGO – April 30, 2024 – Effo
Workers' Comp
News Release
Enlyte and Mitchell Honored as American Business Awards® Winners
Recognition Marks Consecutive Years of Stevie Award-Winning Excellence
Workers' Comp
Article
The Artificial Intelligence Revolution
In the insurance industry, innovation isn't just a buzzword; it's a lifeline to the future.
Workers' Comp
White Paper
Strategies for Combating Mental Health Challenges in Injured Employees
A Guide for Carriers and Employers Are your employees struggling with mental health challenges?
Mitchell
Article
Current Used Vehicle Market Conditions: Q1 2024
February/March 2024 Kontos Kommentary The following commentary is produced by Tom Kontos, Chief Economist, ADESA Auctions.